Cystatin C and Carotid Intima-Media Thickness in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA)

American Journal of Kidney Diseases

Volumn 53, Issue 3, 2009, Pages 389-398

  Bui, Anh L ^a   Katz, Ronit ^b   Kestenbaum, Bryan ^c   de Boer, Ian H ^c   Fried, Linda F ^d   Polak, Joseph F ^e   Wasserman, Bruce A ^f   Sarnak, Mark J ^e   Siscovick, David ^b   Shlipak, Michael G ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; cardiovascular diseases; Cystatin C; intima media thickness (IMT); kidney

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; COMMON CAROTID ARTERY; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERNAL CAROTID ARTERY; KIDNEY FUNCTION; MALE; OUTPATIENT CARE; PROSPECTIVE STUDY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; CYSTATIN C; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUNICA INTIMA; TUNICA MEDIA;

EID: 60149099383     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.06.025     Document Type: Article

References (50)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
2. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
3. Shlipak M.G., Simon J.A., Grady D., Lin F., Wenger N.K., and Furberg C.D. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38 (2001) 705-711
4. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
5. Sarnak M.J., and Levey A.S. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35 suppl 1 (2000) S117-S131
6. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
7. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
8. D'Amico G. Statins and renal diseases: From primary prevention to renal replacement therapy. J Am Soc Nephrol 17 suppl 2 (2006) S148-S152
9. Muntner P., Hamm L.L., Kusek J.W., Chen J., Whelton P.K., and He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140 (2004) 9-17
10. Shlipak M.G., Fried L.F., Crump C., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 (2003) 87-92
11. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., and Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 96 (1997) 1432-1437
12. Burke G.L., Evans G.W., Riley W.A., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 26 (1995) 386-391
13. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
14. Lorenz M.W., von Kegler S., Steinmetz H., Markus H.S., and Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 37 (2006) 87-92
15. Stompor T., Krasniak A., Sulowicz W., et al. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant 20 (2005) 404-412
16. Zoccali C., Benedetto F.A., Maas R., et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13 (2002) 490-496
17. Burdick L., Periti M., Salvaggio A., et al. Relation between carotid artery atherosclerosis and time on dialysis. A non-invasive study in vivo. Clin Nephrol 42 (1994) 121-126
18. Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 24 (2000) 691-695
19. Kawagishi T., Nishizawa Y., Konishi T., et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48 (1995) 820-826
20. Benedetto F.A., Mallamaci F., Tripepi G., and Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12 (2001) 2458-2464
21. Kato A., Takita T., Maruyama Y., Kumagai H., and Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 64 (2003) 1472-1479
22. Nishizawa Y., Shoji T., Maekawa K., et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41 suppl 3 (2003) S76-S79
23. Shoji T., Emoto M., Tabata T., et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 61 (2002) 2187-2192
24. Preston E., Ellis M.R., Kulinskaya E., Davies A.H., and Brown E.A. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 46 (2005) 856-862
25. Shlipak M.G., Fried L.F., Crump C., et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62 (2002) 997-1004
26. Szeto C.C., Chow K.M., Woo K.S., et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol 18 (2007) 1966-1972
27. Zoungas S., Ristevski S., Lightfoot P., et al. Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol 27 (2000) 639-641
28. Leskinen Y., Lehtimaki T., Loimaala A., et al. Carotid atherosclerosis in chronic renal failure-The central role of increased plaque burden. Atherosclerosis 171 (2003) 295-302
29. Zhang L., Zhao F., Yang Y., et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 49 (2007) 786-792
30. Briet M., Bozec E., Laurent S., et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 69 (2006) 350-357
31. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 156 (2002) 871-881
32. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 (1999) 1-8
33. Finney H., Newman D.J., and Price C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 37 (2000) 49-59
34. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 (2008) 395-406
35. Shlipak M.G., Fried L.F., Cushman M., et al. Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293 (2005) 1737-1745
36. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
37. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
38. Watanabe S., Okura T., Liu J., et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res 26 (2003) 895-899
39. Rodondi N., Yerly P., Gabriel A., et al. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Nephrol Dial Transplant 22 (2007) 1107-1114
40. Kramer H., Jacobs Jr. D.R., Bild D., et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 46 (2005) 38-43
41. Ix J.H., Shlipak M., Katz R., et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 50 (2007) 412-420
42. Ix J.H., Katz R., Kestenbaum B., et al. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol 19 (2008) 579-585
43. Moran A, Katz R, Jenny NS, et al: Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (in press)
44. Singh D., Whooley M.A., Ix J.H., Ali S., and Shlipak M.G. Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study. Nephrol Dial Transplant 22 (2007) 1087-1092
45. Knight E.L., Verhave J.C., Spiegelman D., et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004) 1416-1421
46. Keller C.R., Odden M.C., Fried L.F., et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The Health, Aging, and Body Composition Study. Kidney Int 71 (2007) 239-244
47. Shlipak M.G., Katz R., Cushman M., et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 118 (2005) 1416.e25-1416.e31
48. Peralta C.A., Whooley M.A., Ix J.H., and Shlipak M.G. Kidney function and systolic blood pressure new insights from cystatin C: Data from the Heart and Soul Study. Am J Hypertens 19 (2006) 939-946
49. Ix J.H., Shlipak M.G., Chertow G.M., and Whooley M.A. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 115 (2007) 173-179
50. Demer L.L., Tintut Y., and Parhami F. Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens 11 (2002) 437-443